Alkermes publishes 56-week LYBALVI analysis on schizophrenia symptoms

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. NAVN
4. HUMA
5. CHWY
6. USO
7. cASY
8. SPCX
9. EQPT
10. PCT

Go back to Alkermes publishes 56-week LYBALVI analysis on schizophrenia symptoms
ALKERMES (NASDAQ: ALKS) Delayed: 43.84 --0 (-0%)
Previous Close $43.84    52 Week High $80.71 
Open $43.84    52 Week Low $27.14 
Day High $43.84    P/E 337.23 
Day Low $43.84    EPS $0.13 
Volume 12